Cross-sectional study reveals a significant correlation between glycated hemoglobin/HDL ratio and NAFLD in non-diabetic adults, suggesting potential screening benefits.
The purpose of this research was to explore the relationship between the glycated hemoglobin/high-density lipoprotein (HbA1c/HDL-C) ratio and nonalcoholic fatty liver disease (NAFLD) in non-diabetic adults in the United States. Using pertinent variables gathered from the 2017-2020 National Health and Nutrition Examination Survey (NHANES) database, we performed a cross-sectional study including 5,485 adult U.S. citizens. Data were analyzed using multifactor logistic regression, smoothed curve fitting, subgroup, and interaction analyses. Among the 5485 individuals included, there was a significant positive correlation between NAFLD and HbA1c/HDL-C ratio. After adjusting for all covariates, the probability of having NAFLD increased significantly for each unit increase in the log-transformed ratio of this [2.39 (1.94, 2.93)]. Furthermore, we discovered a nonlinear relationship with an inflection point of 1.43 between the ratio and NAFLD. In the end, subgroup analyses revealed a significant interaction between the correlation of this ratio and NAFLD, stratified by the presence or absence of comorbid coronary artery disease (interaction P < 0.05). Our study demonstrated a significant positive correlation between the HbA1c/HDL-C ratio and NAFLD risk in non-diabetic individuals. Thus, the ratio may be a useful correlate of NAFLD risk. Monitoring this ratio through routine physical examination may help to identify high-risk individuals early and then take lifestyle interventions (e.g., dietary modification, increased exercise, etc.) or pharmacological treatments to prevent the development of NAFLD.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: